3-(N-methylpyrrolidin-3-ylmethyl)indole (MPMI) is a tryptamine derivative which acts as a serotonin receptor agonist. It has been studied as an analogue and trace impurity of the anti-migraine drug eletriptan but is otherwise little known.[1][2]

See also

References

  1. ^ FI 105812, Wythes MJ, Macor JE, "Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi", issued 14 April 1993, assigned to Pfizer, Inc. 
  2. ^ US 5607951, Macor JE, Wythes MJ, "Indole derivatives", issued 4 March 1997, assigned to Pfizer, Inc.